trial,pubID,pseudogroup,weeks,group,IgD-/IgM-/IgA-/IgG+/Antigen++ B cells
G002,G002-852,3.0,16,1,958.0
G002,G002-988,3.0,16,3,2269.0
G002,G002-577,4.0,16,2,1759.0
G002,G002-616,3.0,16,1,732.0
G002,G002-931,3.0,16,3,841.0
G002,G002-230,4.0,16,2,2655.0
G002,G002-630,4.0,16,2,1612.0
G002,G002-943,4.0,16,2,1418.0
G002,G002-678,3.0,16,1,712.0
G002,G002-884,3.0,16,3,783.0
G002,G002-796,3.0,16,3,878.0
G002,G002-145,4.0,16,2,2831.0
G002,G002-997,3.0,16,3,756.0
G002,G002-341,4.0,16,2,1202.0
G002,G002-119,4.0,16,2,734.0
G002,G002-619,3.0,16,1,389.0
G002,G002-304,3.0,16,3,138.0
G002,G002-632,3.0,16,3,421.0
G002,G002-855,4.0,16,2,398.0
G002,G002-820,4.0,16,2,1761.0
G002,G002-427,3.0,16,3,350.0
G002,G002-947,4.0,16,2,330.0
G002,G002-758,3.0,16,1,545.0
G002,G002-477,3.0,16,3,389.0
G002,G002-866,3.0,16,3,297.0
G002,G002-969,3.0,16,1,158.0
G002,G002-302,3.0,16,1,295.0
G002,G002-293,4.0,16,2,1780.0
G002,G002-546,3.0,16,1,229.0
G002,G002-278,3.0,16,3,151.0
G002,G002-620,4.0,16,2,312.0
G002,G002-136,4.0,16,2,321.0
G002,G002-595,3.0,16,3,213.0
G002,G002-813,3.0,16,1,178.0
G002,G002-957,4.0,16,2,532.0
G002,G002-462,3.0,16,3,242.0
G002,G002-810,3.0,16,3,294.0
G002,G002-516,3.0,16,1,57.0
G002,G002-480,4.0,16,2,126.0
G002,G002-493,4.0,16,2,352.0
G002,G002-371,3.0,16,3,57.0
G002,G002-905,3.0,16,1,97.0
G002,G002-834,3.0,16,1,72.0
G002,G002-825,3.0,16,3,95.0
